Perceptive Advisors’s OncoSec Medical Incorporated ONCS Stock Holding History

Perceptive Advisors’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-136	Closed	-$17K	–	126
2019 Q1	$17K	Sell	136 -91	-40%	-$12.4K	﹤0.01%	104
2018 Q4	$32K	Hold	227	–	–	﹤0.01%	100
2018 Q3	$70K	Hold	227	–	–	﹤0.01%	113
2018 Q2	$69K	Hold	227	–	–	﹤0.01%	123
2018 Q1	$94K	Buy	+227	New	+$93.1K	﹤0.01%	135

Other funds holding ONCS

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perceptive Advisors's ONCS Position: Q2 2019 in Review

Perceptive Advisors sold out of OncoSec Medical Incorporated (ONCS) in Q2 2019, closing a stake of 136 shares — an estimated $17K sold.

Perceptive Advisors first reported a position in ONCS in Q1 2018 and held it in 5 quarters. The position peaked at $94K in Q1 2018. 20 funds tracked by Wall St. Rank hold ONCS as of Q2 2019.

Perceptive Advisors reported no remaining OncoSec Medical Incorporated position as of Q2 2019 after selling out during the quarter.
Perceptive Advisors sold 136 OncoSec Medical Incorporated shares in Q2 2019, an estimated $17K.
Perceptive Advisors first reported a position in OncoSec Medical Incorporated in Q1 2018 and held it in 5 quarters.
Perceptive Advisors's OncoSec Medical Incorporated position peaked at $94K in Q1 2018.
20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2019.

Based on Perceptive Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.